Skip to main content
. 2008 Jun 27;23(11):3654–3661. doi: 10.1093/ndt/gfn320

Table 3.

Mean Hb by study period (per-protocol population)

Period n Mean (SD) Hb level (g/dl)
Baseline (weeks −4 to 0)
 C.E.R.A. 123 12.0 (0.7)
 DA 126 11.9 (0.6)
Titration (weeks 0 to 28)
 C.E.R.A. 123 12.3 (0.7)
 DA 126 11.9 (0.7)
Evaluation (weeks 29 to 36)
 C.E.R.A. 123 12.1 (1.0)
 DA 126 11.8 (1.0)
Safety (weeks 37 to 52)
 C.E.R.A. 120 11.7 (1.1)
 DA 124 11.7 (1.0)

DA, darbepoetin alfa; Hb, haemoglobin; SD, standard deviation.